Showing results (71-80 of 1,186) with videos related to
Sort By:
Pageof 119
Pharmaceutical Statistics|December 13, 2019
TITE-BOIN-ET: Time-to-event Bayesian optimal interval design to accelerate dose-finding based on both efficacy and toxicity outcomesKentaro Takeda, Satoshi Morita, Masataka TaguriPharmaceutical Statistics|February 24, 2018
Bayesian approach for assessing noninferiority in a three-arm trial with binary endpointSantu Ghosh, Ram C Tiwari, Samiran GhoshPharmaceutical Statistics|January 20, 2023
Improving early phase oncology clinical trial design: The case for finding the optimal biological doseAlan Phillips, Shalini MondalPharmaceutical Statistics|November 10, 2018
Calculation of confidence intervals for a finite population sizeSteven A JuliousPharmaceutical Statistics|November 10, 2018
A simple test for the treatment effect in clinical trials with a sequential parallel comparison design and negative binomial outcomesGosuke Homma, Takashi DaimonPharmaceutical Statistics|October 22, 2016
Accounting for uncertainty in the historical response rate of the standard treatment in single-arm two-stage designs based on Bayesian power functionsFrancesca Matano, Valeria SambuciniPharmaceutical Statistics|December 6, 2016
Α Markov model for longitudinal studies with incomplete dichotomous outcomesOrestis Efthimiou, Nicky Welton, Myrto Samara, et al.Pharmaceutical Statistics|December 10, 2016
Model averaging for treatment effect estimation in subgroupsBjörn Bornkamp, David Ohlssen, Baldur P Magnusson, et al.Pharmaceutical Statistics|November 29, 2016
Application of Bayesian hierarchical models for phase I/II clinical trials in oncologyShinjo Yada, Chikuma HamadaPharmaceutical Statistics|December 15, 2016
Misspecification of at-risk periods and distributional assumptions in estimating COPD exacerbation rates: The resultant bias in treatment effect estimationM Law, M J Sweeting, G C Donaldson, et al.Pageof 119